性别是否仍是造影剂相关药物不良反应的易感因素?随机试验与观察性研究的系统评价与Meta分析
该系统评价与Meta分析纳入18项研究、共10,776例接受造影剂的患者,按研究设计、不良反应类型和CT检查分析性别与造影剂相关药物不良反应发生率的关系。随机对照试验的RR=1.07(95%CI 0.79-1.46,P=0.66),观察性研究的RR=0.77(95%CI 0.58-1.04,P=0.09),按不良反应类型和CT检查分析均未见男女发生率差异。结论为未发现显著差异,未来需研究性别在造影剂与非造影剂药物不良反应中作用不同的原因。
要点
- 按研究设计、不良反应类型和CT检查分层,男女造影剂相关药物不良反应发生率均无显著差异。
- 随机对照试验RR=1.07(95%CI 0.79-1.46,P=0.66),观察性研究RR=0.77(95%CI 0.58-1.04,P=0.09)。
- 作者认为需未来研究解释性别在造影剂与非造影剂药物不良反应中作用不同的原因。
核心结论
- 按研究设计、不良反应类型或CT检查分析,男女患者造影剂相关药物不良反应发生率均无显著差异。
研究设计与样本
- 系统评价与Meta分析,纳入18项研究(随机对照试验和观察性研究),共10,776例接受造影剂的患者;检索3个电子数据库;根据临床条件异质性选择随机效应模型或固定效应模型。
诊断标准与关键数值
- 随机对照试验:性别与造影剂相关药物不良反应的RR=1.07(95%CI 0.79-1.46,P=0.66)。
- 观察性研究:性别与造影剂相关药物不良反应的RR=0.77(95%CI 0.58-1.04,P=0.09)。
- 按不良反应类型和接受CT检查分析,男女造影剂相关药物不良反应发生率无差异。
临床应用与阅片要点
- 作者认为需未来研究确定为何性别在造影剂相关药物不良反应与非造影剂药物不良反应中呈现不同作用。
局限性
- 作者指出需未来研究确定为何性别在造影剂相关药物不良反应与非造影剂药物不良反应中呈现不同作用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To evaluate the role of gender as a risk factor for developing contrast media-associated adverse drug reactions (CM-ADRs) by comparing the incidence of CM-ADR between male and female patients according to study design, ADR type, and computed tomography (CT) examination.
MATERIAL AND METHODS: We systematically searched three electronic databases for eligible studies. In the studies included (n=18), we assessed effect estimates of the relative incidence of CM-ADR, analysed by experimental design, ADR type and CT examination. This was calculated by using a random effects model if clinical conditions showed heterogeneity; otherwise, a fixed effects model was used.
RESULTS: We identified 10,776 patients administered CM. According to the designs, studies were classified into randomised controlled trials (RCTs) and observational studies. Results were as follows: risk ratio (RR)=1.07 (95% confidence interval (CI): 0.79-1.46, P=0.66) for RCTs, and RR=0.77 (95% CI: 0.58-1.04, P=0.09) for observational studies. The results of analysis according to ADR type and for undergoing CT demonstrated that the incidence of CM-ADR did not differ between males and females.
CONCLUSIONS: We found no significant difference in the incidence of CM-ADRs between male and female patients according to study design, ADR type, or CT examination. Future studies to determine why gender has shown different roles as a risk factor between CM-ADRs and non-CM ADRs are needed.
引用
- Lee H, Song S, Oh YK, et al. Is gender still a predisposing factor in contrast-media associated adverse drug reactions? A systematic review and meta-analysis of randomized trials and observational studies. Eur J Radiol. 2017. PMID: 28267554. doi:10.1016/j.ejrad.2017.01.015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。